{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:04:46Z","timestamp":1792789486974,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.diabres.2021.108824","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T13:40:52Z","timestamp":1618926052000},"page":"108824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Metformin extended-release versus metformin immediate-release for adults with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"178","author":[{"given":"Aedrian A.","family":"Abrilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Nico Nahar I.","family":"Pajes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia A.","family":"Jimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2021.108824_b0005","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"10159","key":"10.1016\/j.diabres.2021.108824_b0010","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.diabres.2021.108824_b0015","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2337\/dc17-1962","article-title":"Global economic burden of diabetes in adults: projections from 2015 to 2030","volume":"41","author":"Bommer","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108824_b0020","series-title":"Harrison\u2019s Principles of Internal Medicine","first-page":"2859","article-title":"Diabetes mellitus: management and therapies","author":"Powers","year":"2018"},{"key":"10.1016\/j.diabres.2021.108824_b0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2337\/dc06-9912","article-title":"Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy","volume":"29","author":"Nathan","year":"2006","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.diabres.2021.108824_b0030","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1517\/14656566.7.6.803","article-title":"Metformin extended release for the treatment of type 2 diabetes mellitus","volume":"7","author":"Schwartz","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.diabres.2021.108824_b0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11892-017-0829-8","article-title":"Metformin: new preparations and nonglycemic benefits","volume":"17","author":"Fujita","year":"2017","journal-title":"Curr Diab Rep"},{"issue":"12","key":"10.1016\/j.diabres.2021.108824_b0040","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2021.108824_b0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3810\/pgm.2011.01.2241","article-title":"Advantages of extended-release metformin in patients with type 2 diabetes mellitus","volume":"123","author":"Jabbour","year":"2011","journal-title":"Postgrad Med"},{"issue":"4","key":"10.1016\/j.diabres.2021.108824_b0050","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/dom.12854","article-title":"Understanding and overcoming metformin gastrointestinal intolerance","volume":"19","author":"Bonnet","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"10.1016\/j.diabres.2021.108824_b0055","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1517\/17425255.4.9.1235","article-title":"Clinical development of metformin extended-release tablets for type 2 diabetes: an overview","volume":"4","author":"Schwartz","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.diabres.2021.108824_b0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MJT.0b013e318235f1bb","article-title":"Evolving metformin treatment strategies in type-2 diabetes: from immediate-release metformin monotherapy to extended-release combination therapy","volume":"21","author":"Chacra","year":"2014","journal-title":"Am J Ther"},{"issue":"7","key":"10.1016\/j.diabres.2021.108824_b0065","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.diabres.2021.108824_b0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2021.108824_b0075","doi-asserted-by":"crossref","unstructured":"Higgins JP, Deeks JJ, Altman DG. Special topics in statistics. Cochrane Handbook for Systematic Reviews of Interventions, England, UK: John Wiley & Sons Ltd.; 2008, p. 481\u2013528.","DOI":"10.1002\/9780470712184.ch16"},{"key":"10.1016\/j.diabres.2021.108824_b0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2288-8-56","article-title":"Performing meta-analysis with incomplete statistical information in clinical trials","volume":"8","author":"Ma","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.diabres.2021.108824_b0085","unstructured":"Metformin SR tablet (DuLeNing) and glucophage in patients with type 2 diabetes (CQM-2016). ClinicalTrialsGov 2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03039075."},{"key":"10.1016\/j.diabres.2021.108824_b0090","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2147\/DDDT.S131670","article-title":"Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes","volume":"11","author":"Derosa","year":"2017","journal-title":"Drug Design Dev Ther"},{"issue":"5","key":"10.1016\/j.diabres.2021.108824_b0095","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.clinthera.2018.04.002","article-title":"Comparison of adherence to glimepiride\/metformin sustained release once-daily versus glimepiride\/metformin immediate release BID fixed-combination therapy using the medication event monitoring system in patients with type 2 diabetes","volume":"40","author":"Kim","year":"2018","journal-title":"Clin Ther"},{"issue":"8","key":"10.1016\/j.diabres.2021.108824_b0100","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00125-016-3992-6","article-title":"Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials","volume":"59","author":"DeFronzo","year":"2016","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.diabres.2021.108824_b0105","doi-asserted-by":"crossref","first-page":"e0203946","DOI":"10.1371\/journal.pone.0203946","article-title":"Improved glycemic control with minimal systemic metformin exposure: effects of metformin delayed-release (metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes","volume":"13","author":"Henry","year":"2018","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.diabres.2021.108824_b0110","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1517\/14656566.2016.1149166","article-title":"Will delayed release metformin provide better management of diabetes type 2?","volume":"17","author":"Scheen","year":"2016","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"10.1016\/j.diabres.2021.108824_b0115","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2337\/diacare.29.04.06.dc05-1967","article-title":"Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes","volume":"29","author":"Schwartz","year":"2006","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2021.108824_b0120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0149-2918(03)80093-0","article-title":"Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation","volume":"25","author":"Fujioka","year":"2003","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.diabres.2021.108824_b0125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/ijcp.12071","article-title":"Efficacy and safety of glimepiride\/metformin sustained release once daily vs. glimepiride\/metformin twice daily in patients with type 2 diabetes","volume":"67","author":"Hwang","year":"2013","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2021.108824_b0130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.18203\/2319-2003.ijbcp20160654","article-title":"Comparison of conventional and sustained-release formulation of metformin in type 2 diabetics","volume":"5","author":"Ghorpade","year":"2016","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.diabres.2021.108824_b0135","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.metabol.2007.03.018","article-title":"Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus","volume":"56","author":"Hsieh","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2021.108824_b0140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/dom.13104","article-title":"Metformin extended-release versus immediate-release: an international, randomized, double-blind, head-to-head trial in pharmacotherapy-na\u00efve patients with type 2 diabetes","volume":"20","author":"Aggarwal","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.diabres.2021.108824_b0145","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1742-1241.2008.01733.x","article-title":"The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study: Effects of metformin XR in patients with type 2 diabetes","volume":"62","author":"Gao","year":"2008","journal-title":"Int J Clin Pract"},{"issue":"4","key":"10.1016\/j.diabres.2021.108824_b0150","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/dom.13190","article-title":"Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-na\u00efve Chinese patients: Analysis of results from the CONSENT trial","volume":"20","author":"Ji","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2021.108824_b0155","first-page":"225","article-title":"Dose comparison and side effect profile of metformin extended release versus metformin immediate release","volume":"29","author":"Hameed","year":"2017","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"10.1016\/j.diabres.2021.108824_b0160","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","first-page":"297","article-title":"Addressing reporting biases","author":"Sterne","year":"2008"},{"issue":"4","key":"10.1016\/j.diabres.2021.108824_b0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.diabres.2021.108824_b0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2012.12.026","article-title":"The long and winding road to optimal HbA1c measurement","volume":"418","author":"Little","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1016\/j.diabres.2021.108824_b0175","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2337\/dc16-2271","article-title":"Early glycemic control and magnitude of HbA1c reduction predict cardiovascular events and mortality: population-based cohort study of 24,752 metformin initiators","volume":"40","author":"Svensson","year":"2017","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabres.2021.108824_b0180","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00392-017-1106-1","article-title":"HDL cholesterol: reappraisal of its clinical relevance","volume":"106","author":"M\u00e4rz","year":"2017","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"10.1016\/j.diabres.2021.108824_b0185","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/M20-0864","article-title":"Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis","volume":"173","author":"Tsapas","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2021.108824_b0190","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment. Diabetes Care 2021;44:S111\u201324. https:\/\/doi.org\/10.2337\/dc21-S009.","DOI":"10.2337\/dc21-S009"},{"key":"10.1016\/j.diabres.2021.108824_b0195","unstructured":"Department of Health, Government of the Republic of the Philippines. Drug Price Reference Index. 8th ed. 2020."},{"issue":"14","key":"10.1016\/j.diabres.2021.108824_b0200","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.3390\/ijerph17145242","article-title":"Prices, availability and affordability of medicines with value-added tax exemption: a cross-Sectional survey in the Philippines","volume":"17","author":"Lambojon","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.diabres.2021.108824_b0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2288-14-79","article-title":"Systematic review of methods for individual patient data meta-analysis with binary outcomes","volume":"14","author":"Thomas","year":"2014","journal-title":"BMC Med Res Methodol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721001832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721001832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:20:13Z","timestamp":1759173613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822721001832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":41,"alternative-id":["S0168822721001832"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108824","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-137066\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-137066\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-137066\/v1","asserted-by":"object"}]},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin extended-release versus metformin immediate-release for adults with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108824"}}